Clinical Trial Update: Precision Treatment of Unresectable HCC Guided by Multi-omics Deep Learning Models [Phase 1]

View source ↗

Summary

A Phase 1 trial for unresectable hepatocellular carcinoma using multi-omics deep learning to guide precision therapy and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Chen Xiaoping | Conditions: HCC, Precision Therapy | Phase 1 | Status: RECRUITING